World Health Organization (WHO), in cooperation with partners has initiated the so called Solidarity study. It’s an international clinic study launched to accelerate the process of generating evidence and finding efficient cure for COVID-19, said head of the WHO Montenegro Office, Ms Mina Brajović.
The subject of the research will be four drugs: anti-viral drug tested for ebola treatment, HIV, malaria and multiple sclerosis.
Ms Brajović sys the idea is to make comparison among the drugs and see whether they are working in the context of COVID-19 patients.
“A call for the countries to involve their patients has been made. The goal is to establish whether any of the four cures advances the diseases or its recovery prospects. So far, 76 countries around the world have joined this mega study”, Ms Brajović said.
Procedures and rules for the development of new cures are very rigorous and take long time.
“We expect this procedure to be cut short in time context, by 80%”, Ms Brajović says.
She says that eradication of COVID-19 infection is not possible, not even in mid-term. The risk of infection coming back will be looming for a while.
Warning
Ms Brajović reminds that WHO director general has appealed on countries to refrain from the use of medicines the efficiency of which hasn’t been proved in treating COVID-19.
She points out that there’s still no safe and efficient cure for the treatment of COVID-19 patients.
Medications which haven’t been approved
Ms Brajović stressed that doctors in many countries prescribe medications which haven’t been approved. Use of licensed medicines, without approval of regulatory authorities is known as “off-label use”.
